Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 18805672)

1.

Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment.

Morrow EM, Kane A, Goff DC, Walsh CA.

Schizophr Res. 2008 Dec;106(2-3):265-7. doi: 10.1016/j.schres.2008.08.021. Epub 2008 Sep 20.

2.

[Research progress on nonsyndromic X-linked mental retardation related gene PAK3].

Gao XC, Xi GS, Zhang FC.

Yi Chuan. 2007 May;29(5):523-7. Review. Chinese.

PMID:
17548318
3.

A novel splice mutation in PAK3 gene underlying mental retardation with neuropsychiatric features.

Rejeb I, Saillour Y, Castelnau L, Julien C, Bienvenu T, Taga P, Chaabouni H, Chelly J, Ben Jemaa L, Bahi-Buisson N.

Eur J Hum Genet. 2008 Nov;16(11):1358-63. doi: 10.1038/ejhg.2008.103. Epub 2008 Jun 4.

4.

The four mammalian splice variants encoded by the p21-activated kinase 3 gene have different biological properties.

Kreis P, Rousseau V, Thévenot E, Combeau G, Barnier JV.

J Neurochem. 2008 Aug;106(3):1184-97. doi: 10.1111/j.1471-4159.2008.05474.x. Epub 2008 May 27.

PMID:
18507705
5.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
6.

PAK3 related mental disability: further characterization of the phenotype.

Peippo M, Koivisto AM, Särkämö T, Sipponen M, von Koskull H, Ylisaukko-oja T, Rehnström K, Froyen G, Ignatius J, Järvelä I.

Am J Med Genet A. 2007 Oct 15;143A(20):2406-16.

PMID:
17853471
7.

A mutation in PAK3 with a dual molecular effect deregulates the RAS/MAPK pathway and drives an X-linked syndromic phenotype.

Magini P, Pippucci T, Tsai IC, Coppola S, Stellacci E, Bartoletti-Stella A, Turchetti D, Graziano C, Cenacchi G, Neri I, Cordelli DM, Marchiani V, Bergamaschi R, Gasparre G, Neri G, Mazzanti L, Patrizi A, Franzoni E, Romeo G, Bordo D, Tartaglia M, Katsanis N, Seri M.

Hum Mol Genet. 2014 Jul 1;23(13):3607-17. doi: 10.1093/hmg/ddu070. Epub 2014 Feb 19.

PMID:
24556213
8.

Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia.

Carroll LS, Williams HJ, Walters J, Kirov G, O'Donovan MC, Owen MJ.

Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):844-9. doi: 10.1002/ajmg.b.31231. Epub 2011 Aug 17.

PMID:
21850710
9.

Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics.

Fitzgerald D, Lucas S, Redoblado MA, Winter V, Brennan J, Anderson J, Harris A.

Aust N Z J Psychiatry. 2004 Jul;38(7):501-10.

PMID:
15255822
10.

Premorbid adjustment and neuropsychological performance in schizophrenia.

Silverstein ML, Mavrolefteros G, Close D.

Schizophr Bull. 2002;28(1):157-65.

11.

Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test.

Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G, Benkelfat C, Labelle A.

Arch Gen Psychiatry. 2002 Jul;59(7):662-3. No abstract available.

PMID:
12090821
12.

[Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].

Lecardeur L, Meunier-Cussac S, Dollfus S.

Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Review. French.

PMID:
23528322
13.

Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms.

Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K, Friedrichs H, Radyushkin KA, El-Kordi A, Benseler F, Hannke K, Sperling S, Schwerdtfeger D, Thanhäuser I, Gerchen MF, Ghorbani M, Gutwinski S, Hilmes C, Leppert R, Ronnenberg A, Sowislo J, Stawicki S, Stödtke M, Szuszies C, Reim K, Riggert J, Eckstein F, Falkai P, Bickeböller H, Nave KA, Brose N, Ehrenreich H.

Arch Gen Psychiatry. 2010 Sep;67(9):879-88. doi: 10.1001/archgenpsychiatry.2010.107. Erratum in: Arch Gen Psychiatry. 2010 Oct;67(10):1077.

PMID:
20819981
14.

Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation.

Bienvenu T, des Portes V, McDonell N, Carrié A, Zemni R, Couvert P, Ropers HH, Moraine C, van Bokhoven H, Fryns JP, Allen K, Walsh CA, Boué J, Kahn A, Chelly J, Beldjord C.

Am J Med Genet. 2000 Aug 14;93(4):294-8.

PMID:
10946356
15.

Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR.

Arch Gen Psychiatry. 2000 Sep;57(9):907-13. Erratum in: Arch Gen Psychiatry 2000 Dec;57(12):1122.

PMID:
10986554
17.

Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.

Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, Czerski PM, Hauser J.

Psychiatry Clin Neurosci. 2006 Feb;60(1):70-6.

PMID:
16472361
18.

[Neuropsychological deficits, obstetric complications and premorbid adjustment in patients with the first psychotic episode].

Casar C, Artamendi M, Gutiérrez M, Gil P, García MJ, Cuesta MJ.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1997 Sep-Oct;25(5):303-7. Spanish.

PMID:
9547214
19.

Alteration of synaptic network dynamics by the intellectual disability protein PAK3.

Dubos A, Combeau G, Bernardinelli Y, Barnier JV, Hartley O, Gaertner H, Boda B, Muller D.

J Neurosci. 2012 Jan 11;32(2):519-27. doi: 10.1523/JNEUROSCI.3252-11.2012.

20.

The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus.

Boda B, Alberi S, Nikonenko I, Node-Langlois R, Jourdain P, Moosmayer M, Parisi-Jourdain L, Muller D.

J Neurosci. 2004 Dec 1;24(48):10816-25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk